TRUE Private Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

TRUE Private Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,568	Closed	-$15K	–	647
2020 Q4	$15K	Hold	1,568	–	–	﹤0.01%	497
2020 Q3	$14K	Hold	1,568	–	–	﹤0.01%	455
2020 Q2	$19K	Hold	1,568	–	–	﹤0.01%	416
2020 Q1	$14K	Hold	1,568	–	–	﹤0.01%	408
2019 Q4	$15K	Buy	+1,568	New	+$14K	﹤0.01%	539
2019 Q3	–	Sell	-1,568	Closed	-$14K	–	659
2019 Q2	$14K	Buy	+1,568	New	+$18.9K	﹤0.01%	509
2018 Q4	–	Sell	-108	Closed	-$2.33K	–	842
2018 Q3	$2.33K	Buy	+108	New	+$2.51K	﹤0.01%	1008

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

TRUE Private Wealth Advisors's TEVA Position: Q1 2021 in Review

TRUE Private Wealth Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2021, closing a stake of 1,568 shares — an estimated $15K sold.

TRUE Private Wealth Advisors first reported a position in TEVA in Q3 2018 and held it in 7 quarters. The position peaked at $19K in Q2 2020. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

TRUE Private Wealth Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2021 after selling out during the quarter.
TRUE Private Wealth Advisors sold 1,568 Teva Pharmaceutical Industries Limited shares in Q1 2021, an estimated $15K.
TRUE Private Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q3 2018 and held it in 7 quarters.
TRUE Private Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $19K in Q2 2020.
451 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2021.

Based on TRUE Private Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.